Systemic iron homeostasis and erythropoiesis

IUBMB Life

Volumn 69, Issue 6, 2017, Pages 399-413

  Papanikolaou, George ^a   Pantopoulos, Kostas ^b  

^a HAROKOPIO UNIVERSITY   (Greece)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

erythroferrone; erythropoietin; ferroportin; hepcidin; hypoxia; iron; IRP1; IRP2; transferrin receptor

Indexed keywords

CYTOKINE; HEPCIDIN; IRON; JANUS KINASE; CATION TRANSPORT PROTEIN; HAMP PROTEIN, HUMAN; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; IRP1 PROTEIN, HUMAN; IRP2 PROTEIN, HUMAN; METAL TRANSPORTING PROTEIN 1;

BLOOD FLOW; CELL MATURATION; DISTRIBUTION PARAMETERS; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HEMOCHROMATOSIS; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; IRON ABSORPTION; IRON BALANCE; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; NONHUMAN; REGULATORY MECHANISM; REVIEW; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANEMIA, IRON-DEFICIENCY; CATION TRANSPORT PROTEINS; CELL DIFFERENTIATION; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; HEMOCHROMATOSIS; HEPCIDINS; HOMEOSTASIS; HUMANS; IRON; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; SIGNAL TRANSDUCTION;

EID: 85017392997     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1629     Document Type: Review

References (131)

1. Papanikolaou, G., and Pantopoulos, K. (2005) Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202, 199–211.
2. Gkouvatsos, K., Papanikolaou, G., and Pantopoulos, K. (2012) Regulation of iron transport and the role of transferrin. Biochim. Biophys. Acta 1820, 188–202.
3. Ganz, T. (2013) Systemic iron homeostasis. Physiol. Rev. 93, 1721–1741.
4. Carpenter, C. E., and Mahoney, A. W. (1992) Contributions of heme and nonheme iron to human nutrition. Crit. Rev. Food Sci. Nutr. 31, 333–367.
5. Gulec, S., Anderson, G. J., and Collins, J. F. (2014) Mechanistic and regulatory aspects of intestinal iron absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G397–G409.
6. Vashchenko, G., and MacGillivray, R. T. (2013) Multi-copper oxidases and human iron metabolism. Nutrients 5, 2289–2313.
7. Kovtunovych, G., Eckhaus, M. A., Ghosh, M. C., Ollivierre-Wilson, H., and Rouault, T. A. (2010) Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 116, 6054–6062.
8. Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W., and Kimmelman, A. C. (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509, 105–109.
9. Zhang, Z., Zhang, F., Guo, X., An, P., Tao, Y., and Wang, F. (2012) Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice. Hepatology 56, 961–971. Sep
10. Finch, C. (1994) Regulators of iron balance in humans. Blood 84, 1697–1702.
11. Palis, J. (2014) Primitive and definitive erythropoiesis in mammals. Front. Physiol. 5, 3.
12. Ponka, P. (1997) Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89, 1–25.
13. Shaw, G. C., Cope, J. J., Li, L., Corson, K., Hersey, C., et al. (2006) Mitoferrin is essential for erythroid iron assimilation. Nature 440, 96–100.
14. Sheftel, A. D., Zhang, A. S., Brown, C., Shirihai, O. S., and Ponka, P. (2007) Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 1, 125–132.
15. Levy, J. E., Jin, O., Fujiwara, Y., Kuo, F., and Andrews, N. C. (1999) Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat. Genet. 21, 396–399.
16. An, X., Schulz, V. P., Li, J., Wu, K., Liu, J., et al. (2014) Global transcriptome analyses of human and murine terminal erythroid differentiation. Blood 123, 3466–3477.
17. Harms, K., and Kaiser, T. (2015) Beyond soluble transferrin receptor: old challenges and new horizons. Best Pract. Res. Clin. Endocrinol. Metab. 29, 799–810.
18. Bellelli, R., Federico, G., Matte, A., Colecchia, D., Iolascon, A., et al. (2016) NCOA4 deficiency impairs systemic iron homeostasis. Cell Rep. 14, 411–421.
19. Mancias, J. D., Pontano Vaites, L., Nissim, S., Biancur, D. E., Kim, A. J., et al. (2015) Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. Elife 4, 05.
20. Wang, J., and Pantopoulos, K. (2011) Regulation of cellular iron metabolism. Biochem. J. 434, 365–381.
21. Meyron-Holtz, E. G., Ghosh, M. C., and Rouault, T. A. (2004) Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science 306, 2087–2090.
22. Sanchez, M., Galy, B., Muckenthaler, M. U., and Hentze, M. W. (2007) Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency. Nat. Struct. Mol. Biol. 14, 420–426.
23. Wilkinson, N., and Pantopoulos, K. (2014) The IRP/IRE system in vivo: insights from mouse models. Front. Pharmacol. 5, 176.
24. Shah, Y. M., and Xie, L. (2014) Hypoxia-inducible factors link iron homeostasis and erythropoiesis. Gastroenterology 146, 630–642.
25. Mastrogiannaki, M., Matak, P., Keith, B., Simon, M. C., Vaulont, S., and Peyssonnaux, C. (2009) HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J. Clin. Invest. 119, 1159–1166.
26. Shah, Y. M., Matsubara, T., Ito, S., Yim, S. H., and Gonzalez, F. J. (2009) Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 9, 152–164.
27. Taylor, M., Qu, A., Anderson, E. R., Matsubara, T., Martin, A., et al. (2011) Hypoxia-inducible factor-2alpha mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology 140, 2044–2055.
28. Vanoaica, L., Darshan, D., Richman, L., Schumann, K., and Kuhn, L. C. (2010) Intestinal ferritin h is required for an accurate control of iron absorption. Cell Metab. 12, 273–282.
29. Galy, B., Ferring-Appel, D., Becker, C., Gretz, N., Grone, H. J., et al. (2013) Iron regulatory proteins control a mucosal block to intestinal iron absorption. Cell Rep. 3, 844–857.
30. Cooperman, S. S., Meyron-Holtz, E. G., Olivierre-Wilson, H., Ghosh, M. C., McConnell, J. P., and Rouault, T. A., et al. (2005) Microcytic anemia, erythropoietic protoporphyria and neurodegeneration in mice with targeted deletion of iron regulatory protein 2. Blood 106, 1084–1091.
31. Galy, B., Ferring, D., Minana, B., Bell, O., Janser, H. G., et al. (2005) Altered body iron distribution and microcytosis in mice deficient for iron regulatory protein 2 (IRP2). Blood 106, 2580–2589.
32. Chen, J. J. (2007) Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood 109, 2693–2699.
33. Schranzhofer, M., Schifrer, M., Cabrera, J. A., Kopp, S., Chiba, P., et al. (2006) Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood 107, 4159–4167.
34. Zhu, B. M., McLaughlin, S. K., Na, R., Liu, J., Cui, Y., et al. (2008) Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression. Blood 112, 2071–2080.
35. Kaneko, H., Kobayashi, E., Yamamoto, M., and Shimizu, R. (2012) N- and C-terminal transactivation domains of GATA1 protein coordinate hematopoietic program. J. Biol. Chem. 287, 21439–21449.
36. Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093.
37. Park, C. H., Valore, E. V., Waring, A. J., and Ganz, T. (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276, 7806–7810.
38. Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., et al. (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276, 7811–7819.
39. Preza, G. C., Ruchala, P., Pinon, R., Ramos, E., Qiao, B., et al. (2011) Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J. Clin. Invest. 121, 4880–4888.
40. Zumerle, S., Mathieu, J. R., Delga, S., Heinis, M., Viatte, L., et al. (2014) Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype. Blood 123, 3646–3650.
41. Rishi, G., Wallace, D. F., and Subramaniam, V. N. (2015) Hepcidin: regulation of the master iron regulator. Biosci. Rep. 35, e00192.
42. Ganz, T., and Nemeth, E. (2015) Iron homeostasis in host defence and inflammation. Nat. Rev. Immunol. 15, 500–510.
43. De Domenico, I., Zhang, T. Y., Koening, C. L., Branch, R. W., London, N., et al. (2010) Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest. 120, 2395–2405.
44. Pagani, A., Nai, A., Corna, G., Bosurgi, L., Rovere-Querini, P., et al. (2011) Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood 118, 736–746.
45. Pietrangelo, A. (2016) Iron and the liver. Liver Int. 36, 116–123.
46. Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., et al. (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98, 8780–8785.
47. Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., et al. (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA 99, 4596–4601.
48. Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., et al. (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33, 21–22.
49. Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L., Franchini, P. L., et al. (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36, 77–82.
50. Bridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Purdie, D. M., et al. (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669–673.
51. Nemeth, E., Roetto, A., Garozzo, G., Ganz, T., and Camaschella, C. (2005) Hepcidin is decreased in TFR2 hemochromatosis. Blood 105, 1803–1806.
52. Fleming, R. E., Feng, Q., and Britton, R. S. (2011) Knockout mouse models of iron homeostasis. Annu. Rev. Nutr. 31, 117–137.
53. Jenkitkasemwong, S., Wang, C. Y., Coffey, R., Zhang, W., Chan, A., et al. (2015) SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis. Cell Metab. 22, 138–150.
54. Finberg, K. E., Heeney, M. M., Campagna, D. R., Aydinok, Y., Pearson, H. A., et al. (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat. Genet. 40, 569–571. May
55. Wang, C. Y., and Babitt, J. L. (2016) Hepcidin regulation in the anemia of inflammation. Curr. Opin. Hematol. 23, 189–197.
56. Weiss, G., and Goodnough, L. T. (2005) Anemia of chronic disease. N. Engl. J. Med. 352, 1011–1023.
57. Torti, F. M., and Torti, S. V. (2002) Regulation of ferritin genes and protein. Blood 99, 3505–3516.
58. Guida, C., Altamura, S., Klein, F. A., Galy, B., Boutros, M., et al. (2015) A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood 2, 2265–2275.
59. Sebastiani, G., Wilkinson, N., and Pantopoulos, K. (2016) Pharmacological targeting of the hepcidin/ferroportin axis. Front. Pharmacol. 7, 160.
60. Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., et al. (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38, 531–539. May
61. Healey, E. G., Bishop, B., Elegheert, J., Bell, C. H., Padilla-Parra, S., and Siebold, C. (2015) Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein. Nat. Struct. Mol. Biol. 22, 458–465.
62. Andriopoulos, B., Jr., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., et al. (2009) BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet. 1, 482–487.
63. Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., and Roth, M. P. (2009) Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat. Genet. 1, 478–481.
64. Canali, S., Zumbrennen-Bullough, K. B., Core, A. B., Wang, C. Y., Nairz, M., et al. (2017) Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice. Blood 129, 405–414.
65. Meynard, D., Vaja, V., Sun, C. C., Corradini, E., Chen, S., et al. (2011) Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood 118, 747–756.
66. Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., and Camaschella, C. (2008) The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 8, 502–511.
67. Zhang, A. S., Anderson, S. A., Wang, J., Yang, F., DeMaster, K., et al. (2011) Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein. Blood 117, 1687–1699.
68. Latour, C., Besson-Fournier, C., Meynard, D., Silvestri, L., Gourbeyre, O., et al. (2016) Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin. Hepatology 63, 126–137.
69. Koch, P. S., Olsavszky, V., Ulbrich, F., Sticht, C., Demory, A., et al. (2017) Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis. Blood 129, 415–419.
70. Vujic Spasic, M., Kiss, J., Herrmann, T., Galy, B., Martinache, S., et al. (2008) Hfe acts in hepatocytes to prevent hemochromatosis. Cell Metab. 7, 173–178.
71. Wallace, D. F., Summerville, L., and Subramaniam, V. N. (2007) Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. Gastroenterology 132, 301–310.
72. Gkouvatsos, K., Wagner, J., Papanikolaou, G., Sebastiani, G., and Pantopoulos, K. (2011) Conditional disruption of mouse Hfe2 gene: maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin. Hepatology 54, 1800–1807.
73. Kent, P., Wilkinson, N., Constante, M., Fillebeen, C., Gkouvatsos, K., et al. (2015) Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin. J. Mol. Med. (Berl.) 93, 489–498.
74. Wu, X. G., Wang, Y., Wu, Q., Cheng, W. H., Liu, W., et al. (2014) HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression. Blood 124, 1335–1343.
75. Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13, 399–408.
76. Feder, J. N., Penny, D. M., Irrinki, A., Lee, V. K., Lebron, J. A., et al. (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. USA 95, 1472–1477.
77. Lebrón, J. A., Bennet, M. J., Vaughn, D. E., Chirino, A. J., Snow, P. M., et al. (1998) Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93, 111–123.
78. Schmidt, P. J., Toran, P. T., Giannetti, A. M., Bjorkman, P. J., and Andrews, N. C. (2008) The transferrin receptor modulates hfe-dependent regulation of hepcidin expression. Cell Metab. 7, 205–214.
79. Robb, A., and Wessling-Resnick, M. (2004) Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104, 4294–4299.
80. Johnson, M. B., and Enns, C. A. (2004) Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104, 4287–4293.
81. Gao, J., Chen, J., Kramer, M., Tsukamoto, H., Zhang, A. S., and Enns, C. A., et al. (2009) Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 9, 217–227.
82. Rishi, G., Crampton, E. M., Wallace, D. F., and Subramaniam, V. N. (2013) In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interact. PLoS One 8, e77267.
83. Schmidt, P. J., and Fleming, M. D. (2012) Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2. Am. J. Hematol. 87, 588–595. Jun
84. Pietrangelo, A., Caleffi, A., Henrion, J., Ferrara, F., Corradini, E., et al. (2005) Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 128, 470–479. Feb
85. Wallace, D. F., Summerville, L., Crampton, E. M., Frazer, D. M., Anderson, G. J., and Subramaniam, V. N., et al. (2009) Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 50, 1992–2000.
86. Ramos, E., Kautz, L., Rodriguez, R., Hansen, M., Gabayan, V., et al. (2011) Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 53, 1333–1341. Apr
87. Corradini, E., Meynard, D., Wu, Q., Chen, S., Ventura, P., et al. (2011) Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology 54, 273–284.
88. Ramey, G., Deschemin, J. C., and Vaulont, S. (2009) Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes. Haematologica 94, 765–772.
89. Pietrangelo, A., Dierssen, U., Valli, L., Garuti, C., Rump, A., et al. (2007) STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132, 294–300. Jan
90. Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W., and Muckenthaler, M. U. (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109, 353–358.
91. Wrighting, D. M., and Andrews, N. C. (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108, 3204–3209.
92. Schmidt, P. J. (2015) Regulation of iron metabolism by hepcidin under conditions of inflammation. J. Biol. Chem. 290, 18975–18983.
93. Mayeur, C., Lohmeyer, L. K., Leyton, P., Kao, S. M., Pappas, A. E., et al. (2014) The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6. Blood 123, 2261–2268.
94. Besson-Fournier, C., Latour, C., Kautz, L., Bertrand, J., Ganz, T., et al. (2012) Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood 12;120, 431–439.
95. Kanamori, Y., Sugiyama, M., Hashimoto, O., Murakami, M., Matsui, T., and Funaba, M. (2016) Regulation of hepcidin expression by inflammation-induced activin B. Sci. Rep. 6, 38702–38706.
96. Canali, S., Core, A. B., Zumbrennen-Bullough, K. B., Merkulova, M., Wang, C. Y., et al. (2016) Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: evidence for a role in hepcidin induction by inflammation in male mice. Endocrinology 157, 1146–1162.
97. Besson-Fournier, C., Gineste, A., Latour, C., Gourbeyre, O., Meynard, D., et al. (2017) Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B. Blood 129, 533–536.
98. Shanmugam, N. K., Chen, K., and Cherayil, B. J. (2015) Commensal bacteria-induced interleukin 1beta (IL-1beta) secreted by macrophages up-regulates hepcidin expression in hepatocytes by activating the bone morphogenetic protein signaling pathway. J. Biol. Chem. 290, 30637–30647.
99. Girelli, D., Nemeth, E., and Swinkels, D. W. (2016) Hepcidin in the diagnosis of iron disorders. Blood 127, 2809–2813.
100. Ashby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., et al. (2010) Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica 95, 505–508.
101. Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., et al. (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037–1044.
102. Papanikolaou, G., Tzilianos, M., Christakis, J. I., Bogdanos, D., Tsimirika, K., et al. (2005) Hepcidin in iron overload disorders. Blood 105, 4103–4105.
103. Kattamis, A., Papassotiriou, I., Palaiologou, D., Apostolakou, F., Galani, A., et al. (2006) The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 91, 809–812.
104. Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., and Rivera, S. (2006) Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108, 3730–3735.
105. Vokurka, M., Krijt, J., Sulc, K., and Necas, E. (2006) Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol. Res. 55, 667–674.
106. Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S. H., Staker, P., et al. (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med. 13, 1096–1101. Sep
107. Casanovas, G., Swinkels, D. W., Altamura, S., Schwarz, K., Laarakkers, C. M., et al. (2011) Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II. J. Mol. Med. (Berl.) 89, 811–816.
108. Tamary, H., Shalev, H., Perez-Avraham, G., Zoldan, M., Levi, I., et al. (2008) Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood 112, 5241–5244.
109. Tanno, T., Porayette, P., Sripichai, O., Noh, S. J., Byrnes, C., et al. (2009) Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114, 181–186.
110. Casanovas, G., Vujic Spasic, M., Casu, C., Rivella, S., Strelau, J., et al. (2013) The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice. Haematologica 98, 444–447.
111. Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., and Ganz, T. (2014) Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat. Genet. 46, 678–684.
112. Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., et al. (2016) Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice. Blood 127, 2327–2336.
113. Seldin, M. M., Peterson, J. M., Byerly, M. S., Wei, Z., and Wong, G. W. (2012) Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J. Biol. Chem. 287, 11968–11980.
114. Kautz, L., Jung, G., Du, X., Gabayan, V., Chapman, J., et al. (2015) Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia. Blood 126, 2031–2037.
115. Mirciov, C. S., Wilkins, S. J., Dunn, L. A., Anderson, G. J., and Frazer, D. M. (2017) Characterization of putative erythroid regulators of hepcidin in mouse models of anemia. PLoS One 12, e0171054.
116. Goodnough, L. T. (2007) Erythropoietin and iron-restricted erythropoiesis. Exp. Hematol. 35, 167–172.
117. Kimura, H., Finch, C. A., and Adamson, J. W. (1986) Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia. J. Cell Physiol. 126, 298–306.
118. Choi, J. W. (2007) Serum transferrin receptor concentration and its ratio to bone marrow erythroblasts in iron deficiency anemia and anemia of chronic diseases. Ann. Clin. Lab. Sci. 37, 288–290.
119. Wilkinson, N., and Pantopoulos, K. (2013) IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2alpha mRNA translation. Blood 122, 1658–1668.
120. Ghosh, M. C., Zhang, D. L., Jeong, S. Y., Kovtunovych, G., Ollivierre-Wilson, H., et al. (2013) Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2alpha. Cell Metab. 17, 271–281.
121. Anderson, S. A., Nizzi, C. P., Chang, Y. I., Deck, K. M., Schmidt, P. J., et al. (2013) The IRP1-HIF-2alpha axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. Cell Metab. 17, 282–290.
122. Libregts, S. F., Gutierrez, L., de Bruin, A. M., Wensveen, F. M., Papadopoulos, P., et al. (2011) Chronic IFN-gamma production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood 118, 2578–2588.
123. Richardson, C. L., Delehanty, L. L., Bullock, G. C., Rival, C. M., Tung, K. S., et al. (2013) Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response. J. Clin. Invest. 123, 3614–3623.
124. Bullock, G. C., Delehanty, L. L., Talbot, A. L., Gonias, S. L., Tong, W. H., et al. (2010) Iron control of erythroid development by a novel aconitase-associated regulatory pathway. Blood 116, 97–108.
125. Kim, A., Fung, E., Parikh, S. G., Gabayan, V., Nemeth, E., and Ganz, T. (2016) Isocitrate treatment of acute anemia of inflammation in a mouse model. Blood Cells Mol. Dis. 56, 31–36. Jan
126. Forejtnikova, H., Vieillevoye, M., Zermati, Y., Lambert, M., Pellegrino, R. M., et al. (2010) Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. Blood 116, 5357–5367.
127. Pagani, A., Vieillevoye, M., Nai, A., Rausa, M., Ladli, M., et al. (2015) Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form. Haematologica 100, 458–465.
128. Rishi, G., Secondes, E. S., Wallace, D. F., and Subramaniam, V. N. (2016) Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia. Am. J. Hematol. 91, 812–818.
129. Nai, A., Lidonnici, M. R., Rausa, M., Mandelli, G., Pagani, A., et al. (2015) The second transferrin receptor regulates red blood cell production in mice. Blood 125, 1170–1179.
130. Pantopoulos, K. (2015) TfR2 links iron metabolism and erythropoiesis. Blood 12, 1055–1056.
131. Camaschella, C., Pagani, A., Nai, A., and Silvestri, L. (2016) The mutual control of iron and erythropoiesis. Int. J. Lab. Hematol. 38, 20–26.